Evidence map›Paper›PMID 36792809›Full record

ArticleCommunications biology2023

Enhanced hexamerization of insulin via assembly pathway rerouting revealed by single particle studies.

Freja Bohr, Søren S-R Bohr, Narendra Kumar Mishra, Nicolás Sebastian González-Foutel, Henrik Dahl Pinholt, Shunliang Wu, Emilie Milan Nielsen, Min Zhang, Magnus Kjaergaard, Knud J Jensen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Freja BohrDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-4587-3345
Søren S-R BohrDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-8107-2465
Narendra Kumar Mishra *Department of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.
Nicolás Sebastian González-Foutel *Department of Molecular Biology and Genetics, The Danish Research Institute for Translational Neuroscience (DANDRITE), Nordic EMBL Partnership for Molecular Medicine, and Center for Proteins in Memory PROMEMO, Danish National Research Foundation, Aarhus University, Aarhus, Denmark.
Henrik Dahl PinholtDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.
Shunliang WuDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.
Emilie Milan NielsenDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.
Min ZhangDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-2797-5049
Magnus KjaergaardDepartment of Molecular Biology and Genetics, The Danish Research Institute for Translational Neuroscience (DANDRITE), Nordic EMBL Partnership for Molecular Medicine, and Center for Proteins in Memory PROMEMO, Danish National Research Foundation, Aarhus University, Aarhus, Denmark.
Knud J JensenDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark. kjj@chem.ku.dk.ORCID 0000-0003-3525-5452
Nikos S HatzakisDepartment of Chemistry & Nanoscience Center, University of Copenhagen, Copenhagen, Denmark. hatzakis@chem.ku.dk.ORCID 0000-0003-4202-0328
University of Copenhagen · DKAarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin formulations with diverse oligomerization states are the hallmark of interventions for the treatment of diabetes. Here using single-molecule recordings we firstly reveal that insulin oligomerization can operate via monomeric additions and secondly quantify the existence, abundance and kinetic characterization of diverse insulin assembly and disassembly pathways involving addition of monomeric, dimeric or tetrameric insulin species. We propose and experimentally validate a model where the insulin self-assembly pathway is rerouted, favoring monomeric or oligomeric assembly, by solution concentration, additives and formulations. Combining our practically complete kinetic characterization with rate simulations, we calculate the abundance of each oligomeric species from nM to mM offering mechanistic insights and the relative abundance of all oligomeric forms at concentrations relevant both for secreted and administrated insulin. These reveal a high abundance of all oligomers and a significant fraction of hexamer resulting in practically halved bioavailable monomer concentration. In addition to providing fundamental new insights, the results and toolbox presented here can be universally applied, contributing to the development of optimal insulin formulations and the deciphering of oligomerization mechanisms for additional proteins.

Indexed as

InsulinInsulin, Regular, HumanKineticsInsulinInsulin, Regular, Human

Identifiers

PMID36792809
PMCPMC9932072
OpenAlexW4320914675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.